[48-hour continuous infusion of vindesine (followed by cisplatin) in advanced lung cancer. Chronopharmacokinetic data and clinical efficacy].
Focan
C
C
Clinique Saint-Joseph-Sainte-Elisabeth, Liège, Belgique.
Doalto
L
L
Mazy
V
V
Levi
F
F
Bruguerolle
B
B
Cano
J P
JP
Rahmani
R
R
Hecquet
B
B
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002940:Circadian Rhythm; D002945:Cisplatin / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014751:Vindesine / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use
D002945:Cisplatin; D014751:Vindesine
Vindésine en perfusion continue de 48 heures (suivie de cisplatine) dans le cancer pulmonaire avancé. Données chronopharmacocinétiques et efficacité clinique.